Biopharmaceutical research companies are conducting or have conducted more than 3,700 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 3,700 clinical trials, more than 2,000 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
“Clinical trials are a key research tool for advancing medical knowledge and patient care. They also are an economic driver, not only to the regions where they are performed, but also nationally and globally. Additionally, clinical trial results can help health care decision-makers direct resources to the strategies and treatments that work best and are safe. Patients from minority populations should be adequately represented in clinical trials since treatments affect a range of patient groups differently.” --Russell E. Poland, Ph.D. Vice President for Research Professor, Department of Psychiatry, Meharry Medical College